Prevalence of asymptomatic vertebral fractures in late-onset Pompe disease

J Clin Endocrinol Metab. 2015 Feb;100(2):401-6. doi: 10.1210/jc.2014-2763. Epub 2014 Nov 14.

Abstract

Context: Bone fragility and low bone mass have been reported in small case series of patients with Pompe disease with severely reduced muscle strength or immobilization.

Objective: Our objective was to determine the prevalence of morphometric vertebral fractures and to evaluate bone mass in adults with late-onset Pompe disease.

Design: We conducted a multicenter cross-sectional observational study from August 2012 to December 2013.

Study setting: All subjects were outpatients referred to University Referral Centers.

Patients: PATIENTS included 22 late-onset Pompe disease patients with progressive proximal myopathy and minimal respiratory involvement without other diseases affecting bone mass.

Main outcome measure: The prevalence of morphometric vertebral fractures was systematically assessed by semiquantitative analysis of lateral spine x-rays (T4-L5).

Results: A high prevalence of morphometric vertebral fractures was found. At least 1 vertebral fracture was present in 17 of 22 patients (77%). All vertebral fractures were asymptomatic. Bone mineral density was normal in 36.5% of the patients, whereas 36.5% were osteopenic and 27% were osteoporotic in at least 1 site. Fracture prevalence was independent of muscular and respiratory functional parameters and of genotype.

Conclusions: Our data show for the first time that asymptomatic and atraumatic vertebral fractures occur frequently in late-onset Pompe disease patients without a significant impairment of bone mass. Screening for asymptomatic vertebral fractures should be routinely performed in Pompe disease irrespective of the disease severity. Fracture risk should be confirmed in longitudinal studies.

Publication types

  • Multicenter Study
  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Bone Density / physiology*
  • Comorbidity
  • Cross-Sectional Studies
  • Female
  • Glycogen Storage Disease Type II / diagnostic imaging
  • Glycogen Storage Disease Type II / epidemiology*
  • Humans
  • Male
  • Middle Aged
  • Osteoporosis / diagnostic imaging
  • Osteoporosis / epidemiology*
  • Prevalence
  • Radiography
  • Spinal Fractures / diagnostic imaging
  • Spinal Fractures / epidemiology*
  • Young Adult